cagrilintide vs retatrutide for Weight Loss and Metabolic Health CagriSema vs Retatrutide: Amylin/GLP-1 Combination

The maintenance phase has different metabolic needs, different gut dynamics, and far less support available, noted Valenton

You recently published an editorial about the additional benefits of GLP-1 receptor agonists

Conclusions The market access landscape for GLP-1 therapies in mid-2026 is characterized by extremely high demand but severely constrained distribution through insurer and PBM systems

In UK clinical settings, the recognised standard diluent for injectable medicines is Water for Injections BP (single-use, preservative-free), and the choice of diluent must always follow the licensed product's Summary of Product Characteristics (SmPC)

doi: 10.1210/en.2008-1479 186 WilliamsDL

Rhodes, MD, an obesity medicine